Old Web
English
Sign In
Acemap
>
authorDetail
>
J Louwers
J Louwers
University Medical Center Utrecht
Medicine
Internal medicine
Infliximab
Crohn's disease
Gastroenterology
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P414 Obesity is associated with a higher risk of immunogenicity to adalimumab, but not to infliximab in patients with Inflammatory Bowel Disease
2021
Journal of Crohn's and Colitis
Remi Mahmoud
J Schultheiss
J Louwers
M van der Kaaij
B van Hellemondt
Nofel Mahmmod
P van Boeckel
Bindia Jharap
Herma H. Fidder
Bas Oldenburg
Show All
Source
Cite
Save
Citations (0)
Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease.
2021
Alimentary Pharmacology & Therapeutics
J Schultheiss
Remi Mahmoud
J Louwers
Michiel T. van der Kaaij
Boris P. van Hellemondt
Petra G. Van Boeckel
Nofel Mahmmod
Bindia Jharap
Herma H. Fidder
Bas Oldenburg
Show All
Source
Cite
Save
Citations (0)
DOP75 Loss-of-response and immunogenicity following immunomodulator withdrawal from anti-tumour necrosis factor alpha combination therapy: Results from a large retrospective cohort study
2021
Journal of Crohn's and Colitis
Remi Mahmoud
J Schultheiss
J Louwers
M van der Kaaij
B van Hellemondt
Nofel Mahmmod
P van Boeckel
Bindia Jharap
Herma H. Fidder
Bas Oldenburg
Show All
Source
Cite
Save
Citations (0)
P299 Loss-of-response to anti-tumour necrosis factor-α critically depends on treatment duration in patients with Inflammatory Bowel Disease
2021
Journal of Crohn's and Colitis
J Schultheiss
Remi Mahmoud
J Louwers
M van der Kaaij
B van Hellemondt
P van Boeckel
Nofel Mahmmod
Bindia Jharap
Herma H. Fidder
Bas Oldenburg
Show All
Source
Cite
Save
Citations (0)
1